company background image
PAA logo

PharmAust ASX:PAA Stock Report

Last Price

AU$0.38

Market Cap

AU$146.5m

7D

5.6%

1Y

257.1%

Updated

28 Mar, 2024

Data

Company Financials

PAA Stock Overview

PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally.

PAA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

PharmAust Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PharmAust
Historical stock prices
Current Share PriceAU$0.38
52 Week HighAU$0.54
52 Week LowAU$0.065
Beta1.25
1 Month Change-1.32%
3 Month Change226.09%
1 Year Change257.14%
3 Year Change282.65%
5 Year Change861.54%
Change since IPO-95.83%

Recent News & Updates

Recent updates

Here's Why We're Not At All Concerned With PharmAust's (ASX:PAA) Cash Burn Situation

Mar 31
Here's Why We're Not At All Concerned With PharmAust's (ASX:PAA) Cash Burn Situation

Here's Why PharmAust Limited's (ASX:PAA) CEO Compensation Is The Least Of Shareholders Concerns

Nov 03
Here's Why PharmAust Limited's (ASX:PAA) CEO Compensation Is The Least Of Shareholders Concerns

Is PharmAust (ASX:PAA) In A Good Position To Deliver On Growth Plans?

May 30
Is PharmAust (ASX:PAA) In A Good Position To Deliver On Growth Plans?

This Is The Reason Why We Think PharmAust Limited's (ASX:PAA) CEO Might Be Underpaid

Oct 14
This Is The Reason Why We Think PharmAust Limited's (ASX:PAA) CEO Might Be Underpaid

What Does PharmAust's (ASX:PAA) CEO Pay Reveal?

Feb 14
What Does PharmAust's (ASX:PAA) CEO Pay Reveal?

Shareholder Returns

PAAAU PharmaceuticalsAU Market
7D5.6%2.0%1.3%
1Y257.1%42.7%11.5%

Return vs Industry: PAA exceeded the Australian Pharmaceuticals industry which returned 44.7% over the past year.

Return vs Market: PAA exceeded the Australian Market which returned 11.6% over the past year.

Price Volatility

Is PAA's price volatile compared to industry and market?
PAA volatility
PAA Average Weekly Movement19.6%
Pharmaceuticals Industry Average Movement11.2%
Market Average Movement8.8%
10% most volatile stocks in AU Market17.1%
10% least volatile stocks in AU Market3.2%

Stable Share Price: PAA's share price has been volatile over the past 3 months.

Volatility Over Time: PAA's weekly volatility has increased from 13% to 20% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000n/aMichael Thurnhttps://www.pharmaust.com

PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, neurological diseases, and viral infections. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer.

PharmAust Limited Fundamentals Summary

How do PharmAust's earnings and revenue compare to its market cap?
PAA fundamental statistics
Market capAU$146.47m
Earnings (TTM)-AU$7.75m
Revenue (TTM)AU$3.71m

39.5x

P/S Ratio

-18.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PAA income statement (TTM)
RevenueAU$3.71m
Cost of RevenueAU$1.34m
Gross ProfitAU$2.38m
Other ExpensesAU$10.12m
Earnings-AU$7.75m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.02
Gross Margin64.00%
Net Profit Margin-208.74%
Debt/Equity Ratio0%

How did PAA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.